CarboneC., PiroG., TamburrinoA., MinaM. M., ZaniniS., TortoraG., and MelisiD. “TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance”. JOP. Journal of the Pancreas, Vol. 14, no. 5S, Sept. 2013, p. 562, doi:10.6092/1590-8577/1866.